SCHEMBL9385237

SCHEMBL9385237

COC(=O)OC1=C(C)NC(C)=C(OC(=O)OC)C1c1cccc2ncc(-c3ccccc3)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.42
AXL P30530 4/20 0.41
GSK3A P49840 3/20 0.38
GSK3B P49841 3/20 0.38
SGK1 O00141 3/20 0.38
CAMKK2 Q96RR4 2/20 0.38
NEK1 Q96PY6 1/20 0.38
PSMB5 P28074 1/20 0.37
MET P08581 1/20 0.36
RIPK1 Q13546 2/20 0.36
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP2C19 P33261 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ABCB11 O95342 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
CYP2D6 P10635 2/20 0.35
KMT2A Q03164 2/20 0.35
KCNH2 Q12809 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9200857 0.90 MAPT (0.41) NR3C2AXLGSK3AGSK3BSGK1
SCHEMBL9580964 0.84 CYP2C9 (0.51) NR3C2AXLSGK1CAMKK2NEK1
SCHEMBL9705890 0.83 NR3C2 (0.40) NR3C2AXLGSK3AGSK3BPSMB5
SCHEMBL9580965 0.82 CYP2C9 (0.48) NR3C2AXLSGK1CAMKK2NEK1
SCHEMBL9463271 0.82 NR3C2 (0.44) NR3C2AXLGSK3AGSK3BSGK1
SCHEMBL9140284 0.79 NR3C2 (0.44) NR3C2AXLSGK1CAMKK2NEK1
SCHEMBL9463382 0.78 NR3C2 (0.51) NR3C2CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9205840 0.78 KDM4E (0.48) NR3C2AXLMETNPSR1KMT2A
SCHEMBL9467948 0.78 NR3C2 (0.62) NR3C2AXLMETCYP1A2CYP3A4
SCHEMBL9415520 0.77 MAPT (0.37) NR3C2RIPK1CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0538690-B1 Arylquinoline substituted 1,4-dihydropyridine dicarboxylic derivatives, process for their preparation and their use as drugs BAYER AG (DE) 1994-09-28 EP disclosed
EP-0538690-A1 Arylquinoline substituted 1,4-dihydropyridine dicarboxylic derivatives, process for their preparation and their use as drugs BAYER AG (DE) 1993-04-28 EP disclosed